1. Home
  2. BKU vs NVCR Comparison

BKU vs NVCR Comparison

Compare BKU & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BankUnited Inc.

BKU

BankUnited Inc.

HOLD

Current Price

$45.81

Market Cap

3.3B

Sector

Finance

ML Signal

HOLD

Logo NovoCure Limited

NVCR

NovoCure Limited

HOLD

Current Price

$12.99

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BKU
NVCR
Founded
2009
2000
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Savings Institutions
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
1.5B
IPO Year
2011
2015

Fundamental Metrics

Financial Performance
Metric
BKU
NVCR
Price
$45.81
$12.99
Analyst Decision
Hold
Buy
Analyst Count
12
6
Target Price
$42.92
$28.42
AVG Volume (30 Days)
1.0M
1.8M
Earning Date
01-21-2026
10-30-2025
Dividend Yield
2.70%
N/A
EPS Growth
44.85
N/A
EPS
3.54
N/A
Revenue
$1,016,093,000.00
$642,269,000.00
Revenue This Year
$14.68
$9.75
Revenue Next Year
$5.73
$5.62
P/E Ratio
$13.00
N/A
Revenue Growth
10.45
11.17
52 Week Low
$28.21
$10.70
52 Week High
$46.56
$34.13

Technical Indicators

Market Signals
Indicator
BKU
NVCR
Relative Strength Index (RSI) 72.41 56.12
Support Level $44.71 $10.79
Resistance Level $45.11 $13.94
Average True Range (ATR) 1.00 0.61
MACD 0.15 0.20
Stochastic Oscillator 77.44 69.68

Price Performance

Historical Comparison
BKU
NVCR

About BKU BankUnited Inc.

BankUnited Inc is a bank holding company with one wholly owned subsidiary, BankUnited. The bank provides a full range of banking services through banking centers located throughout Florida, as well as New York City. The company is a commercially focused regional bank focusing on small and middle-market businesses, but also provides certain commercial lending and deposit products on a national platform. The Bank offers a comprehensive suite of commercial lending and deposit products through an Atlanta office focused on the Southeast region, certain commercial lending and deposit products through national platforms and certain consumer deposit products through an online channel.

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

Share on Social Networks: